Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Keyaki

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Nihon Geka Hokan. Archiv Fur Japanische Chirurgie|November 1, 1985
[Analysis of effector T lymphocyte subpopulations necessary to mediate semisyngeneic tumor rejection in mice]A Keyaki
No Shinkei Geka. Neurological Surgery|November 24, 1999
[Combined modality therapy for malignant lymphoma of the primary central nervous system: a preliminary report of a new chemotherapeutic regimen with "PEACE"]A Keyaki, S Nabeshima, S Waga
No Shinkei Geka. Neurological Surgery|August 10, 1999
[Clinical study of symptomatic Rathke cleft cyst]A Keyaki, Y J Kim, S Nabeshima
No to Shinkei = Brain and Nerve|April 1, 1989
[Differential diagnosis and origin of epithelial cysts in the central nervous system--report of seven cases and review of literature]A Keyaki, A Hirano, J F Llena
Neurologia Medico-Chirurgica|December 1, 1988
[Asymptomatic and symptomatic colloid cysts of the third ventricle]A Keyaki, A Hirano, J F Llena
Neurologia Medico-Chirurgica|February 1, 1989
[Asymptomatic and symptomatic Rathke's cleft cysts. Histological study of 45 cases]A Keyaki, A Hirano, J F Llena
Immunology|September 1, 1985
Effector mechanisms of syngeneic anti-tumour responses in mice. I. Establishment and characterization of an exogenous IL-2-independent cytotoxic T-lymphocyte line specific for radiation-induced leukaemia RL male 1K Kuribayashi, A Keyaki, S Sakaguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1984
[rInterferon-alpha A (Ro 22-8181) therapy for patients with malignant brain tumors]S Otsuka, J Yamashita, A Keyaki, et al.
No to Shinkei = Brain and Nerve|November 7, 2000
[Clinical problems in the treatment of primary central nervous system malignant lymphoma]A Keyaki, S Nabeshima, S Hashimoto, et al.
Surgical Neurology|February 1, 1981
Intracranial angiolipomaJ Takeuchi, H Handa, A Keyaki, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Nihon Geka Hokan. Archiv Fur Japanische Chirurgie|November 1, 1985
[Analysis of effector T lymphocyte subpopulations necessary to mediate semisyngeneic tumor rejection in mice]A Keyaki
No Shinkei Geka. Neurological Surgery|November 24, 1999
[Combined modality therapy for malignant lymphoma of the primary central nervous system: a preliminary report of a new chemotherapeutic regimen with "PEACE"]A Keyaki, S Nabeshima, S Waga
No Shinkei Geka. Neurological Surgery|August 10, 1999
[Clinical study of symptomatic Rathke cleft cyst]A Keyaki, Y J Kim, S Nabeshima
No to Shinkei = Brain and Nerve|April 1, 1989
[Differential diagnosis and origin of epithelial cysts in the central nervous system--report of seven cases and review of literature]A Keyaki, A Hirano, J F Llena
Neurologia Medico-Chirurgica|December 1, 1988
[Asymptomatic and symptomatic colloid cysts of the third ventricle]A Keyaki, A Hirano, J F Llena
Neurologia Medico-Chirurgica|February 1, 1989
[Asymptomatic and symptomatic Rathke's cleft cysts. Histological study of 45 cases]A Keyaki, A Hirano, J F Llena
Immunology|September 1, 1985
Effector mechanisms of syngeneic anti-tumour responses in mice. I. Establishment and characterization of an exogenous IL-2-independent cytotoxic T-lymphocyte line specific for radiation-induced leukaemia RL male 1K Kuribayashi, A Keyaki, S Sakaguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1984
[rInterferon-alpha A (Ro 22-8181) therapy for patients with malignant brain tumors]S Otsuka, J Yamashita, A Keyaki, et al.
No to Shinkei = Brain and Nerve|November 7, 2000
[Clinical problems in the treatment of primary central nervous system malignant lymphoma]A Keyaki, S Nabeshima, S Hashimoto, et al.
Surgical Neurology|February 1, 1981
Intracranial angiolipomaJ Takeuchi, H Handa, A Keyaki, et al.
Pageof 4